DarcyAKruegerMDPhD

Director, Tuberous Sclerosis Clinic and Clack Endowed Chair in Tuberous Sclerosis, Professor of Clinical Pediatrics and Neurology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine

Join to view full profile

Dr. Krueger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Krueger's full profile

Already have an account?

Office
3333 Burnet Ave
# ML5021
Cincinnati, OH 45229
Phone+1 513-636-9985

Fax+1 866-213-7089

Summary

Dr. Darcy Krueger is a Child Neurologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. He received his medical degree from Saint Louis University School of Medicine and has been in practice 15 years. He is experienced in neurofibromatosis, tuberous sclerosis, and rasopathies.

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Child Neurology, 2004 - 2007
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2002 - 2004
Saint Louis University School of MedicineClass of 2002

Certifications & Licensure

FL State Medical License 2020 - Present
OH State Medical License 2002 - 2026
IN State Medical License 2021 - 2025
KY State Medical License 2021 - 2025
NY State Medical License 2022 - 2025
PA State Medical License 2023 - 2024
NC State Medical License 2020 - 2022
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

Manuel R. Gomez Award Tuberous Sclerosis Alliance, 2019

Clinical Trials

Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC) Start of enrollment: 2010 Jan 01
Completed
Phase 1, Phase 2
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) Start of enrollment: 2011 Jan 01
Completed
Phase 2
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC) Start of enrollment: 2013 Jan 01
Completed
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC) Start of enrollment: 2015 May 01
Recruiting
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants Start of enrollment: 2020 Sep 08
Completed
Phase 1, Phase 2
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study Start of enrollment: 2021 Oct 13
Recruiting
Phase 2
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations Start of enrollment: 2015 May 01
Recruiting
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex Start of enrollment: 2016 Dec 01
Completed
Phase 2
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC Start of enrollment: 2012 Sep 01
Completed
Join now to see all

Publications & Presentations

PubMed

30 citations
Tuber Locations Associated with Infantile Spasms Map to a Common Brain Network
Alexander L. Cohen, Brechtje P F Mulder, Anna K. Prohl, Louis Soussand, Peter E. Davis
Annals of Neurology. 2021-01-21
949 citations
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Hope Northrup, Darcy A. Krueger
Pediatric Neurology. 2013-10-01
201 citations
Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing.
Magdalena E. Tyburczy, Kira A. Dies, Jennifer Glass, S. Camposano, Yvonne Chekaluk
Plos Genetics. 2015-11-05

Journal Articles

High Vigabatrin Dosage Is Associated with Lower Risk of Infantile Spasms Relapse Among Children with Tuberous Sclerosis Complex
Mustafa Sahin, Jurriaan M Peters, Monisha Goyal, Darcy A Krueger, Shaun A Hussain, ScienceDirect
Tuberin Regulates Prostaglandin Receptor–Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells
Darcy A Krueger, David N Franz, David J Kwiatkowski, Kantha Medepalli, Brian J Siroky, Jamie K Capal, Clinical Cancer Research

Press Mentions

KHN Morning BriefingJune 1st, 2022
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management RecommendationsAugust 3rd, 2021
Brown University’s Felix Chan Wins Young Investigator Award from Developmental Synaptopathies ConsortiumMay 19th, 2021
Join now to see all